Spray Toux/Spray para a Tosse PT

Dénomination commerciale

Spray Toux/Spray para a Tosse PT

08056300622116

805630062FTPR819S

Numéro de référence/catalogue

FTPR81

GS1

Classe IIa

Législation applicable

MDR [Règlement (UE) 2017/745 relatif aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

Aloemoss Spray is a medical device composed of substances, not sterile, intended for short term invasive contact with respect to body orifices (oral cavity), designed for the treatment of sore throat and cough in children (3+), adolescents and adults.

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• V9017ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES

1 avertissement enregistré — faire défiler le panneau pour tout voir.

• If you do not notice appreciable results after a short period of treatment (7 days), contact your doctor. Do not take it if you are allergic, intolerant or hypersensitive to any component. Do not administer the product to children under three years of age. Do not use the product after the expiry date printed on the package. The expiry date refers to the product in its intact package, and properly stored. Do not use in case the package is not intact. Keep out of the reach of children. Do not use for purposes other than that for which the product is intended. No side effects associated by used the device have been observed. If you notice the appearance of side effects, inform your doctor. Any serious incident that has occurred in relation to the device should be reported to the manufacturer and the Competent Authority. In case of any undesired event always seek medical advice. Do not exceed the recommended daily dose. Since no data on use during pregnancy and lactation are available, its use is generally not recommended as a precaution due to lack of experimental data. Even if no side effects are known, it is recommended not to use the product during pregnancy or breastfeeding. In any case, consult your doctor before taking it. In the event of concomitant pharmacological treatment, although no interactions with drugs are known, it is advisable to consult a doctor before use. The period of validity after the first opening of the spray is 30 days.

  AUTRE